Mounjaro and Mental Health: What People Commonly Report

The relationship between GLP-1 receptor agonists and mental health is an active area of research, and individual experiences vary widely. Some people report feeling more emotionally even and positive as their relationship with food and their body changes; others notice periods of low mood, irritability, anxiety, or emotional flatness, particularly in the early weeks of treatment or after a dose adjustment.

What people commonly report

• Low mood or low motivation — sometimes described as a general flatness or reduced interest in things that normally bring pleasure
• Irritability or mood swings — often noted in the days shortly after an injection
• Anxiety or heightened worry — reported by some, though not a universally common effect
• Emotional changes linked to appetite shifts — the reduction in "food noise" that many people experience can itself feel unfamiliar and emotionally complex

What the evidence currently says

Regulatory bodies, including the MHRA, have monitored this area and continue to review reports. At present, GLP-1 medicines are not confirmed to cause depression or suicidal ideation in the way some early signals suggested, but monitoring remains ongoing. You should report any mental health side effects to your healthcare professional and to your national reporting scheme (such as the UK's Yellow Card scheme) so that post-market safety data continues to build.

It is also worth noting that significant weight change and changes in eating behaviour can themselves influence mood independently of any direct effect of the medicine. Untangling the two is genuinely difficult, which is why tracking matters.

For a broader picture of reported effects, see our guide to common Mounjaro side effects or read about mental health and mood on Wegovy if you are comparing experiences across GLP-1 medicines.

If you are experiencing thoughts of self-harm, severe depression, or any mental health crisis, contact your healthcare professional or emergency services promptly — do not wait for your next scheduled appointment.

One of the most useful things you can do when experiencing any mood-related change is to record it consistently — noting when it happened, how intense it felt, and whether it followed a pattern (for example, in the days after each injection). That kind of log can be genuinely valuable when you sit down with your prescriber to discuss how treatment is going.

GLP Trackr's side-effect and mood tracking is the feature built for exactly this. Each day's check-in lets you log your mood, energy levels, and any symptoms you're experiencing, and over time the app surfaces patterns you might not notice day to day. If low mood tends to appear on days two and three after each dose, that pattern becomes visible — and it becomes something concrete to bring to your doctor rather than a vague sense that something feels off.

You can also use the daily check-in to note sleep quality and energy alongside mood, since these are closely connected and often relevant to how your prescriber interprets what you're experiencing. The app's doctor report feature lets you generate a summary of your tracked data to share at appointments, which is especially useful when discussing something as nuanced as mental health changes.

For more on what other people on tirzepatide commonly experience, the full Mounjaro side effects overview covers the wider range of reported effects, and our Mounjaro side effects hub brings together guidance on managing and logging them.

GLP Trackr helps you observe and record — it is not a substitute for clinical support. If mental health symptoms are severe, persistent, or feel urgent, please speak with your healthcare professional promptly. Any decisions about continuing or adjusting your treatment belong with your prescriber, who knows your full history.

Start logging your mood and wellbeing alongside your treatment — GLP Trackr is free to try for 7 days on the App Store and Google Play.